The role of infection in the pathogenesis of catastrophic antiphospholipid syndrome--molecular mimicry?
Asherson, R.A.; Shoenfeld, Y.
Journal of Rheumatology 27(1): 12-14
2000
ISSN/ISBN: 0315-162X PMID: 10648011 Document Number: 516869
Document emailed within 1 workday
Related Documents
Rafai, M.A.; Fadel, H.; Gam, I.; Hakim, K.; El-Moutawakkil, B.; Kissani, N.; Slassi, I. 2006: Reccurent stroke revealing catastrophic antiphospholipid syndrome with hepatitis C viral infection Revue Neurologique (Paris) 162(11): 1131-1134Le Loët, X.; Vittecoq, O.; Jouen-Beades, F.; Tron, F. 1997: Catastrophic antiphospholipid syndrome Presse Medicale 26(3): 131-134
Wisłowska, M.łg. 2015: Catastrophic antiphospholipid syndrome Wiadomosci Lekarskie 68(3): 271-273
Vivaldi, P.; Andreotti, C.; Mazzon, C.; Pedrazzoli, M. 1994: A "primitive" catastrophic antiphospholipid syndrome Haematologica 79(2): 173-176
Larson, M.; Lindaman, B. 2019: Catastrophic Antiphospholipid Syndrome Presenting with Genitourinary Manifestations South Dakota Medicine: the Journal of the South Dakota State Medical Association 72(10): 464-466
Carlesimo, B.; Monarca, C.; Rizzo, M.I.; Conte, F.; Scuderi, N. 2011: Comparison of surgical methods in catastrophic antiphospholipid syndrome (CAPS) Il Giornale di Chirurgia 32(3): 110-112
Zoli, A.; D'Agostino, M.A.; Pompa, A.; Altomonte, L.; Mirone, L.; Magarò, A. 2000: Failure of aggressive anticoagulant therapy in catastrophic antiphospholipid syndrome Clinical and Experimental Rheumatology 18(1): 113
Saïkali, N.; Dubost, J.J.; Durif, F.; Dordain, G. 2001: Catastrophic antiphospholipid syndrome revealed by a cerebrovascular accident: a case report Revue Neurologique (Paris) 157(11 Part 1): 1424-1426
Jacobson, T.B.; Kolade, V.O.; Kapadia, A.S. 2010: Catastrophic antiphospholipid antibody syndrome in a young woman in the postpartum period Tennessee Medicine: Journal of the Tennessee Medical Association 103(10): 35-36; 39
Tektonidou, M.G.; Sotsiou, F.; Moutsopoulos, H.M. 2008: Antiphospholipid syndrome (APS) nephropathy in catastrophic, primary, and systemic lupus erythematosus-related APS Journal of Rheumatology 35(10): 1983-1988
Albani, S. 1994: Infection and molecular mimicry in autoimmune diseases of childhood Clinical and Experimental Rheumatology 12(Suppl 10): S35-S41
Roep, B.O. 2003: Molecular mimicry in autoimmune neurological disease after viral infection Current Medicinal Chemistry 10(19): 1939-1943
Ohmura, K.; Oku, K.; Atsumi, T. 2014: The pathogenesis, diagnosis and treatment of antiphospholipid syndrome Nihon Rinsho. Japanese Journal of Clinical Medicine 72(7): 1309-1313
Arnout, J. 1996: The pathogenesis of the antiphospholipid syndrome: a hypothesis based on parallelisms with heparin-induced thrombocytopenia Thrombosis and Haemostasis 75(4): 536-541
Kozlovskaia, N.L.; Shakhnova, E.A.; Kushnir, V.V.; Shilov, E.M. 2004: Low-molecular heparins in the treatment of APS-nephropathy in primary and secondary antiphospholipid syndrome Terapevticheskii Arkhiv 76(9): 35-40
Russell, A.S. 1989: Molecular mimicry--a chimera? Journal of Rheumatology 16(12): 1528-1529
Liblau, R.; Gautam, A.M. 2000: HLA, molecular mimicry and multiple sclerosis Reviews in Immunogenetics 2(1): 95-104
Oleszak, E.L. 1994: Molecular mimicry between Fc receptors and viral antigens Archivum Immunologiae et Therapiae Experimentalis 42(2): 83-88
Witkowska, D. 1999: Molecular mimicry of bacteria as a factor in bacterial pathogenicity Postepy Higieny i Medycyny Doswiadczalnej 53(4): 545-559
Boffa, M.C.; Piette, J.C. 1996: Questions-answers about antiphospholipid-protein antibodies and the "antiphospholipid antibody syndrome" Annales de Medecine Interne 147 Suppl. 1: 54-56